| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy
|
Wenthe, Jessica
|
|
|
70 |
10 |
p. 2851-2865
|
artikel
|
| 2 |
Brief in vitro IL-12 conditioning of CD8 + T Cells for anticancer adoptive T cell therapy
|
Salem, Mohamed Labib
|
|
|
70 |
10 |
p. 2751-2759
|
artikel
|
| 3 |
Clinical significance of peripheral TCR and BCR repertoire diversity in EGFR/ALK wild-type NSCLC treated with anti-PD-1 antibody
|
Nakahara, Yoshiro
|
|
|
70 |
10 |
p. 2881-2892
|
artikel
|
| 4 |
Combining UBR5 and CD163+ tumor-associated macrophages better predicts prognosis of clear cell renal cell carcinoma patients
|
Wang, Chao
|
|
|
70 |
10 |
p. 2925-2935
|
artikel
|
| 5 |
Comparative assessment of manual chart review and ICD claims data in evaluating immunotherapy-related adverse events
|
Nashed, Andrew
|
|
|
70 |
10 |
p. 2761-2769
|
artikel
|
| 6 |
Correction to: Cancer testis antigen Cyclin A1 harbors several HLA‑A*02:01‑restricted T cell epitopes, which are presented and recognized in vivo
|
Teck, Anja Tatjana
|
|
|
70 |
10 |
p. 3055
|
artikel
|
| 7 |
Correction to: CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion
|
Wang, Fei
|
|
|
70 |
10 |
p. 3057-3059
|
artikel
|
| 8 |
Correction to: Effect of chemoradiotherapy on the proportion of circulating lymphocyte subsets in patients with limited‑stage small cell lung cancer
|
Chen, Yamei
|
|
|
70 |
10 |
p. 2877-2879
|
artikel
|
| 9 |
Effect of chemoradiotherapy on the proportion of circulating lymphocyte subsets in patients with limited-stage small cell lung cancer
|
Chen, Yamei
|
|
|
70 |
10 |
p. 2867-2876
|
artikel
|
| 10 |
Efficacy and safety of anti-PD-1-based therapy in combination with PARP inhibitors for patients with advanced solid tumors in a real-world setting
|
Wu, Zhaozhen
|
|
|
70 |
10 |
p. 2971-2980
|
artikel
|
| 11 |
Identified lung adenocarcinoma metabolic phenotypes and their association with tumor immune microenvironment
|
Wu, Xian-Ning
|
|
|
70 |
10 |
p. 2835-2850
|
artikel
|
| 12 |
Immune checkpoint inhibitors-associated pericardial disease: a systematic review of case reports
|
Inno, Alessandro
|
|
|
70 |
10 |
p. 3041-3053
|
artikel
|
| 13 |
Immune modulating activity of the CHK1 inhibitor prexasertib and anti-PD-L1 antibody LY3300054 in patients with high-grade serous ovarian cancer and other solid tumors
|
Do, Khanh T.
|
|
|
70 |
10 |
p. 2991-3000
|
artikel
|
| 14 |
Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies
|
Bareham, Bethany
|
|
|
70 |
10 |
p. 2737-2750
|
artikel
|
| 15 |
Multiplexed single-cell pathology reveals the association of CD8 T-cell heterogeneity with prognostic outcomes in renal cell carcinoma
|
Murakami, Tetsushi
|
|
|
70 |
10 |
p. 3001-3013
|
artikel
|
| 16 |
Natural killer cells efficiently target multiple myeloma clonogenic tumor cells
|
Leivas, Alejandra
|
|
|
70 |
10 |
p. 2911-2924
|
artikel
|
| 17 |
Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients
|
Dréno, Brigitte
|
|
|
70 |
10 |
p. 3015-3030
|
artikel
|
| 18 |
Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer
|
Chiang, Shu-Fen
|
|
|
70 |
10 |
p. 2937-2950
|
artikel
|
| 19 |
Potentially functional variants of ERAP1, PSMF1 and NCF2 in the MHC-I-related pathway predict non-small cell lung cancer survival
|
Yang, Sen
|
|
|
70 |
10 |
p. 2819-2833
|
artikel
|
| 20 |
Prognostic value of PD-L1 combined positive score in patients with upper tract urothelial carcinoma
|
Chen, Chien-Hsu
|
|
|
70 |
10 |
p. 2981-2990
|
artikel
|
| 21 |
Sarcopenia and the risk of adverse events in patients treated with immune checkpoint inhibitors: a systematic review
|
Guzman-Prado, Yuli
|
|
|
70 |
10 |
p. 2771-2780
|
artikel
|
| 22 |
Sex-specific hormone changes during immunotherapy and its influence on survival in metastatic renal cell carcinoma
|
Tulchiner, Gennadi
|
|
|
70 |
10 |
p. 2805-2817
|
artikel
|
| 23 |
Simultaneously target of normal and stem cells-like gastric cancer cells via cisplatin and anti-CD133 CAR-T combination therapy
|
Han, Yang
|
|
|
70 |
10 |
p. 2795-2803
|
artikel
|
| 24 |
The clinical implication of soluble PD-L1 (sPD-L1) in patients with breast cancer and its biological function in regulating the function of T lymphocyte
|
Han, Baojuan
|
|
|
70 |
10 |
p. 2893-2909
|
artikel
|
| 25 |
The impact of selenium on regulatory T cell frequency and immune checkpoint receptor expression in patients with diffuse large B cell lymphoma (DLBCL)
|
Dehghani, Mehdi
|
|
|
70 |
10 |
p. 2961-2969
|
artikel
|
| 26 |
TIGIT promotes CD8+T cells exhaustion and predicts poor prognosis of colorectal cancer
|
Liang, Rongpu
|
|
|
70 |
10 |
p. 2781-2793
|
artikel
|
| 27 |
Tumor immune microenvironment in brain metastases from gynecologic malignancies
|
Gill, Corey M.
|
|
|
70 |
10 |
p. 2951-2960
|
artikel
|
| 28 |
Tumor morphology and location associate with immune cell composition in pleomorphic sarcoma
|
Wustrack, Rosanna L.
|
|
|
70 |
10 |
p. 3031-3040
|
artikel
|
Tijdschrift beschrijving